<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We present evidence that different B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, in bone marrow, have different relationships to stroma </plain></SENT>
<SENT sid="1" pm="."><plain>Marrow core biopsies from 46 patients with B-cell <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> were immunostained with antibodies for distinct stromal cells </plain></SENT>
<SENT sid="2" pm="."><plain>Cases included follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL), <z:hpo ids='HP_0011010'>chronic</z:hpo> lymphocytic <z:mpath ids='MPATH_336'>leukaemia</z:mpath>/small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e>), mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e>), lymphoplasmacytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (LPL), and nodal, extranodal and splenic marginal zone <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (NMZL, MALT, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e>) </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:mpath ids='MPATH_458'>normal</z:mpath> marrow, low-affinity nerve growth factor receptor (LNGFR) highlighted a fine network of adventitial reticular cells (ARC) </plain></SENT>
<SENT sid="4" pm="."><plain>The nodular aggregates of <z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e>, NMZL, MALT and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e> were characterized by distortion of the ARC network and downregulation of LNGFR </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, the aggregates of FL, LPL and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> were composed of linear arrays of ARC in tight association with individual <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells </plain></SENT>
<SENT sid="6" pm="."><plain>LNFGR+ was upregulated in ARC associated with the aggregates in FL, LPL and focally in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MCL</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Upregulation of CD35, vascular cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> molecule (VCAM-1) and CD40 on ARC was noted exclusively in FL </plain></SENT>
<SENT sid="8" pm="."><plain>Marrow lymphoid aggregates in <z:e sem="disease" ids="C1302547" disease_type="Neoplastic Process" abbrv="">CLL/SLL</z:e>, NMZL, MALT and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SMZL</z:e> probably grow by displacing the pre-existing marrow stroma, while FL and LPL maintain a close association with the ARC network </plain></SENT>
<SENT sid="9" pm="."><plain>In FL, expression of follicular dendritic cell-associated markers is modulated in pre-existing marrow stromal cells </plain></SENT>
</text></document>